A molecule has been discovered which may aid scientists in the fight against Alzheimer's disease, with the resulting medicine believed to possibly halt the progress of the condition.
In research carried out by students at Katholieke Universitiet (KU) Leuven in Belgium, it was highlighted that current treatments can, at best, limit memory loss during the first phases of the degenerative condition, though the new experiment has found a way to deactivate the primary antagonist.
By deactivating y-secretase, the plaques which are associated with the condition can be deactivated without affecting the other functions of the gene.
It is added that with the toxic side-effects cut away from the treatment, it could also be administered to prevent Alzheimer's disease ever occurring in many, which requires it to be further researched and developed - a process which could take up to 15 years.
KU Leuven is one of the oldest universities in Europe, established in 1425 and offering teaching in English and Dutch and accommodating 33,000 students.
Please click here for advice to help you find the right type of care.